Literature DB >> 10748417

Intrafamilial phenotypic variability in Engelmann disease (ED): are ED and Ribbing disease the same entity?

Y Makita1, G Nishimura, S Ikegawa, T Ishii, Y Ito, A Okuno.   

Abstract

We report on clinical and radiologic manifestations in a 3-generation Japanese family with Engelmann disease (ED) or progressive diaphyseal dysplasia. A large variation of phenotype was remarkable among 12 affected family members. Of the 12 patients, 7 had full manifestations of ED, such as bilateral, symmetrical diaphyseal sclerosis of long bones with myopathy and limb pain, whereas the other 5 exhibited only segmental (rhizomelic and/or mesomelic) involvement and asymmetric diaphyseal sclerosis without any clinical symptoms. The phenotype of the latter group of patients resembled Ribbing disease (RD). We propose that ED and RD represent phenotypic variation of the same disorder. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10748417     DOI: 10.1002/(sici)1096-8628(20000313)91:2<153::aid-ajmg15>3.0.co;2-u

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development.

Authors:  Eiríkur Steingrimsson; Lino Tessarollo; Bhavani Pathak; Ling Hou; Heinz Arnheiter; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

2.  Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3.

Authors:  M Ghadami; Y Makita; K Yoshida; G Nishimura; Y Fukushima; K Wakui; S Ikegawa; K Yamada; S Kondo; N Niikawa; H a Tomita
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Pain improvement in Camurati-Engelmann disease after anti-TNFα therapy.

Authors:  Sónia Moreira; Bernardo Cunha; Nelson Pedro Jesus; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2017-11-28

4.  Multiple diaphyseal sclerosis (Ribbing disease): what about neridronate?

Authors:  M Di Carlo; F Silveri; M Tardella; M Carotti; F Salaffi
Journal:  Osteoporos Int       Date:  2016-04-22       Impact factor: 4.507

Review 5.  Treatment of Ribbing disease with 5-year follow-up and literature review.

Authors:  L L Zhang; W M Jiang; H L Yang; Z-P Luo
Journal:  Osteoporos Int       Date:  2017-01-18       Impact factor: 4.507

Review 6.  Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.

Authors:  K Janssens; F Vanhoenacker; M Bonduelle; L Verbruggen; L Van Maldergem; S Ralston; N Guañabens; N Migone; S Wientroub; M T Divizia; C Bergmann; C Bennett; S Simsek; S Melançon; T Cundy; W Van Hul
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

Review 7.  Camurati-Engelmann Disease.

Authors:  Wim Van Hul; Eveline Boudin; Filip M Vanhoenacker; Geert Mortier
Journal:  Calcif Tissue Int       Date:  2019-02-05       Impact factor: 4.333

Review 8.  The Erlenmeyer flask bone deformity in the skeletal dysplasias.

Authors:  Maha A Faden; Deborah Krakow; Fatih Ezgu; David L Rimoin; Ralph S Lachman
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

9.  Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.

Authors:  Michael P Whyte; William G Totty; Deborah V Novack; Xiafang Zhang; Deborah Wenkert; Steven Mumm
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

10.  Ribbing disease: Uncommon cause of a common symptom.

Authors:  Nishikant Avinash Damle; Manish Patnecha; Praveen Kumar; Ankur Gadodia; Kiran Subbarao; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.